Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1158 Articles

Jon C. Ogg | Sep 20, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson,…

Chris Lange | Sep 14, 2017 at 1:35 PM EDT

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Sep 11, 2017 at 8:50 AM EDT

Achillion Pharma Slides After Hep C Deal Is Terminated

Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration…

Paul Ausick | Aug 23, 2017 at 4:01 PM EDT

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

Johnson & Johnson, Cisco Systems, Disney, and Caterpillar led the DJIA downward on Wednesday.

Paul Ausick | Aug 21, 2017 at 9:04 AM EDT

10 Companies with the Biggest 2016 Share Buybacks

Companies included on the S&P 500 index bought back more than $500 billion in stock last year and have bought…

Paul Ausick | Aug 15, 2017 at 9:00 AM EDT

Amazon: The Devil You Know and the Devil You Don’t

One thing investors wanted to hear on conference calls this earnings season was how companies are responding to Amazon. One…

Paul Ausick | Aug 8, 2017 at 4:01 PM EDT

Merck, DuPont Lead Dow Lower on Tuesday

Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes…

Jon C. Ogg | Aug 2, 2017 at 1:20 PM EDT

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its…

Paul Ausick | Jul 24, 2017 at 4:01 PM EDT

GE, Nike Guide DJIA Down on Monday

General Electric, Nike, Home Depot, and Johnson & Johnson led the DJIA lower Monday.

Jon C. Ogg | Jul 21, 2017 at 9:16 AM EDT

Top Analyst Upgrades & Downgrades: American Superconductor, Chipotle, Groupon, J&J, Juniper, Occidental, Wells Fargo and Many More

Stocks have pulled back a tad from all-time highs, and the market indexes were indicated to have a slight drop…

Chris Lange | Jul 21, 2017 at 8:37 AM EDT

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the…

Jon C. Ogg | Jul 20, 2017 at 9:24 AM EDT

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes…

Chris Lange | Jul 18, 2017 at 9:58 AM EDT

Johnson & Johnson Shares Slip Following Mixed Earnings

Johnson & Johnson (NYSE: JNJ) released its fiscal second-quarter earnings report before the markets opened on Tuesday. The company posted…

Chris Lange | Jul 15, 2017 at 10:25 AM EDT

Goldman Sachs, IBM and More Dow Stocks Reporting Next Week

24/7 Wall St. has put together a preview of General Electric, Microsoft and other Dow Jones Industrial Average companies scheduled…

1 … 32 33 34 35 36 … 78

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Why Pfizer Is Pushing the Dow to All-Time Highs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Achillion Pharma Slides After Hep C Deal Is Terminated

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

10 Companies with the Biggest 2016 Share Buybacks

Amazon: The Devil You Know and the Devil You Don’t

Merck, DuPont Lead Dow Lower on Tuesday

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

GE, Nike Guide DJIA Down on Monday

Top Analyst Upgrades & Downgrades: American Superconductor, Chipotle, Groupon, J&J, Juniper, Occidental, Wells Fargo and Many More

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

Johnson & Johnson Shares Slip Following Mixed Earnings

Goldman Sachs, IBM and More Dow Stocks Reporting Next Week

The December 2026 Opportunity Zone Deadline That Lets a Tech Founder Defer $2.4 Million of Capital Gain Tax for Eight More Years

The $10 Million Tax-Free Gain a Startup Engineer Is About to Realize Under Section 1202 — and the Five-Year Holding Period Trap

Will SpaceX’s $1.75 Trillion IPO Valuation Survive Friday’s Market Rout?

The Life Insurance Move That Lets a Retiring 64-Year-Old Take the Higher Single-Life Pension and Still Leave His Spouse $720,000 Protected

Three Unexpected Reasons Your Social Security Check Could Quietly Get Smaller

The Life Insurance Move That Lets a Retiring 64-Year-Old Take the Higher Single-Life Pension and Still Leave His Spouse $720,000 Protected

The December 2026 Opportunity Zone Deadline That Lets a Tech Founder Defer $2.4 Million of Capital Gain Tax for Eight More Years

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top Analyst Upgrades and Downgrades: Biogen, Electronic Arts, Gap, Intuit, J&J, 3M, Intercept, AutoZone and More

Why Pfizer Is Pushing the Dow to All-Time Highs

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Achillion Pharma Slides After Hep C Deal Is Terminated

Johnson & Johnson, Disney Lead DJIA Lower Wednesday

10 Companies with the Biggest 2016 Share Buybacks

Amazon: The Devil You Know and the Devil You Don’t

Merck, DuPont Lead Dow Lower on Tuesday

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

GE, Nike Guide DJIA Down on Monday

Top Analyst Upgrades & Downgrades: American Superconductor, Chipotle, Groupon, J&J, Juniper, Occidental, Wells Fargo and Many More

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

Johnson & Johnson Shares Slip Following Mixed Earnings

Goldman Sachs, IBM and More Dow Stocks Reporting Next Week

The December 2026 Opportunity Zone Deadline That Lets a Tech Founder Defer $2.4 Million of Capital Gain Tax for Eight More Years

The $10 Million Tax-Free Gain a Startup Engineer Is About to Realize Under Section 1202 — and the Five-Year Holding Period Trap

Will SpaceX’s $1.75 Trillion IPO Valuation Survive Friday’s Market Rout?

Featured Reads

The Life Insurance Move That Lets a Retiring 64-Year-Old Take the Higher Single-Life Pension and Still Leave His Spouse $720,000 Protected

Three Unexpected Reasons Your Social Security Check Could Quietly Get Smaller